Live Breaking News & Updates on Investigational Higher Dose

Stay updated with breaking news from Investigational higher dose. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Biogen Inc.: New Data at Cure SMA 2021 Highlight the Long-Term Efficacy of SPINRAZA (nusinersen) and Biogen's Commitment to Innovation in SMA Therapy

New data analysis suggests an investigational higher dose of SPINRAZA may lead to clinically meaningful improvements in motor functionA NURTURE study analysis shows 92 percent of children who initiated ....

United States , United Kingdom , Mike Hencke , Charles Weissmann , Walter Gilbert , Heinz Schaller , Kenneth Murray , Alfred Sandrock Jr , Allison Parks , Head Of Research , Ionis Pharmaceuticals Inc , Research Clinical Care Meeting , Biogen Inc , Exchange Commission , Findings Support Continued Development , American Academy Of Neurology , National Institute Of Neurological Disorders , Clinical Care Meeting , Alfred Sandrock , Investigational Higher Dose , Philadelphia Infant Test , Neuromuscular Disorders , Reinforce Long Term Efficacy , Broad Range , Presentations Include , Higher Dose ,